Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ATRIPLA vs AVACINCAPTAD PEGOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ATRIPLA vs AVACINCAPTAD PEGOL: Safety Overview

Metric ATRIPLA AVACINCAPTAD PEGOL
Total FAERS Reports 179 202
Deaths Reported 2 3
Death Rate 1.1% 1.5%
Hospitalizations 30 2
Average Patient Age 46.5 yrs 82.3 yrs
% Female Patients N/A 61.9%
FDA Approval Date N/A Aug 4, 2023
Manufacturer N/A Astellas Pharma US, Inc.
Route N/A INTRAVITREAL
Marketing Status N/A Prescription